# HCQ_AZ_COVID_19
Reanalysis of data from Gautret et al. (2020) IJAA, DOI : 10.1016/j.ijantimicag.2020.105949 
using survival analyses to provide effect size estimates for treatment.
(hydroxychloroquine for COVID-19 trial)
